evidencegaps
Primary study · included by 1 review

Adjuvant therapy improves survival in pT4aN0 oral cavity squamous cell carcinoma with bone invasion.

Stanford-Moore 2022 · Stanford-Moore Gaelen B, Sola Ana Marija, Chan Jason, et al. · American journal of otolaryngology · 2022

Included by

Two-year follow-up outcomes of neoadjuvant therapy in oral squamous cell carcinoma: an exploratory systematic review and meta-analysis.
Non-Cochrane · prognostic · 2026 · cited as Stanford-Moore 2022 · Reference list 25-34; Table 1; Fig 4-8

The review does not say which of its outcomes this study informs.

1 including review in total.